Table 3.
HCMV | miRNA | Target | Function | Reference |
---|---|---|---|---|
Cellular
targets |
miR-UL112 | MICB | Immune evasion | [32] |
miR-US25-2-3p | TIMP3 | Immune evasion | [70] | |
miR-UL112-3p | TLR2 | Immune evasion | [72] | |
miRNA UL148D | CCL5 | Immune evasion | [73] | |
miR-US4-1 | ERAP1 | Immune evasion | [71] | |
miR-US25-1 | CD147, CCNE2, EID1, BRCC3, MAPRE2, H3F3B, ATP6V0CP1 | Interrupts cell cycle | [11] | |
miR-US25-2-3p | eIF4A1 | Immune evasion | [74] | |
Viral targets | miR-UL112-1 | IE72, UL114 | Favors latency | [75] |
3 The table presents HCMV miRNAs, their targets (cellular/viral), and their modes of action. Abbreviations: MICB, MHC class-I-related chain B; TIMP3, tissue inhibitors of metalloprotease 3; TLR2, Toll-like receptor 2; CCL5, chemokine (C-C motif) ligand 5; ERAP1, endoplasmic reticulum aminopeptidase 1; CD147, collagenase stimulatory factor; CCNE2, cyclin E2; EID1, EP300 interacting inhibitor of differentiation 1; BRCC3, BRCA1/BRCA2-containing complex-subunit 3; MAPRE2, microtubule-associated proteins, RP/EB family, member 2; H3F3B, histone proteins; ATP6V0CP1, ATPase-V0 subunit C pseudogene 1 protein; eIF4A1, eukaryotic initiation factor 4A1; IE72, immediate early trans-activator.